Eisai
4523.T
#2011
Rank
โ‚น664.89 B
Marketcap
โ‚น2,359
Share price
-0.53%
Change (1 day)
-41.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น186.17. In 2022 the company made an earnings per share (EPS) of โ‚น136.67 a decrease over its 2021 EPS that were of โ‚น606.75.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6031.42%
2022โ‚น136.67-77.48%
2021โ‚น606.75-41.88%
2020โ‚น1,044-0.94%
2019โ‚น1,05452.59%
2018โ‚น690.62124.17%
2017โ‚น308.08-49.42%
2016โ‚น609.1537.08%
2015โ‚น444.39-11.75%
2014โ‚น503.53-3.23%
2013โ‚น520.34-18.56%
2012โ‚น638.96-15.51%
2011โ‚น756.28-3.75%
2010โ‚น785.78-1.36%
2009โ‚น796.61